Use of recombinant FVIIa for intraperitoneal coagulopathic bleeding in a septic patient.
about
Recombinant activated factor VIIa for the treatment of bleeding in major abdominal surgery including vascular and urological surgery: a review and meta-analysis of published dataRecombinant activated factor VII in patients at high risk of bleeding.Recombinant activated factor VIIa and hemostasis in critical care: a focus on traumaPro/con debate: does recombinant factor VIIa have a role to play in the treatment of patients with acute nontraumatic hemorrhage?Factor VIIa induces anti-inflammatory signaling via EPCR and PAR1.
P2860
Use of recombinant FVIIa for intraperitoneal coagulopathic bleeding in a septic patient.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Use of recombinant FVIIa for intraperitoneal coagulopathic bleeding in a septic patient.
@ast
Use of recombinant FVIIa for intraperitoneal coagulopathic bleeding in a septic patient.
@en
type
label
Use of recombinant FVIIa for intraperitoneal coagulopathic bleeding in a septic patient.
@ast
Use of recombinant FVIIa for intraperitoneal coagulopathic bleeding in a septic patient.
@en
prefLabel
Use of recombinant FVIIa for intraperitoneal coagulopathic bleeding in a septic patient.
@ast
Use of recombinant FVIIa for intraperitoneal coagulopathic bleeding in a septic patient.
@en
P2093
P1476
Use of recombinant FVIIa for intraperitoneal coagulopathic bleeding in a septic patient.
@en
P2093
Craig F Fischer
Holly L Neville
Keith Hoots
P304
P356
10.1016/S0149-7944(02)00690-6
P577
2003-07-01T00:00:00Z